The Khavinson Peptide Tradition
Epithalon research originates from Vladimir Khavinson's laboratory at the St. Petersburg Institute of Bioregulation and Gerontology. Khavinson's broader research program produced a family of short bioregulator peptides derived from organ extracts — Epithalon is the best-known of these, derived from bovine pineal extracts.
The research-grade synthetic peptide is available as Epithalon 50mg.
Sequence: A Tetrapeptide
Epithalon is a four-amino-acid sequence (Ala-Glu-Asp-Gly). At 390 Da molecular weight, it is one of the smallest research peptides — small enough that oral administration has been studied, though parenteral routes dominate the research literature.
Telomerase Activation Research
The Khavinson literature reports that Epithalon induces telomerase activity in somatic cells — a property not shared by most short peptides. The proposed mechanism involves chromatin-level gene expression modulation rather than direct telomerase enzyme binding.
Published research outcomes:
- Telomerase activity increase in hematopoietic and somatic cells
- Telomere length changes over extended study windows
- Extension of cellular replicative lifespan in culture
- Modulation of aging-associated gene expression
The telomerase claim is the most cited and the most debated — modern replication studies outside the Khavinson group are limited, which is worth understanding when positioning Epithalon in a research protocol.
Pineal Gland Context
The pineal extract origin is not incidental. The Khavinson group framed Epithalon research specifically around pineal-associated aging — melatonin rhythm, circadian regulation, and endocrine aging markers. This framing situates Epithalon in a broader neuroendocrine research context rather than as a purely telomerase-focused compound.
Russian Literature and Translation
A significant portion of the Epithalon research literature is Russian-language and dates to the 1990s–2000s Khavinson era. Modern English-language research has built on this foundation but is not as voluminous. Researchers working with Epithalon benefit from awareness of both literature streams.
Modern Research Protocols
Typical modern research protocols involve:
- Daily or every-other-day subcutaneous dosing
- Cycled windows — 10–20 day intensive periods separated by washout intervals
- Outcome markers: telomerase activity assays, telomere length measurement (qPCR-based), aging-associated transcript panels
The cycled rhythm reflects the Khavinson-era protocols more than any pharmacokinetic constraint — Epithalon has a short plasma half-life.
Research Handling
Standard lyophilized peptide handling applies: −20°C long-term storage, 2–8°C after reconstitution, 28-day reconstituted use window. Purity should be >98% HPLC verified. See Epithalon 50mg for the research-grade vial.